Unravel Initiates RVL-001 Clinical Program in Colombia for Rett Syndrome With Clinical Trial Tool Translation
/PRNewswire/ -- Unravel Biosciences, Inc., ("Unravel"), an AI-enabled therapeutics company to advance drugs for complex diseases, today announced the...
United States Vanderbilt Kennedy Center Biosciences Inc Develop Validated Translations Rett Syndrome Behavioral Questionnaire Key Step
Source: prnewswire.com